CNS Pharmaceuticals, Inc.
$5.52
+0.01 (+0.10%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +13.9%
- 3 Months
- +1.5%
- YTD
- +5.2%
- 1 Year
- -12.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 254.2%
- Largest decline max drawdown, since Aug 2025
- -79.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.55
Own CNSP?
See how CNSP contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.